Portal de Periódicos da CAPES

Hundreds of basal cell carcinomas in a Gorlin‐Goltz syndrome patient cured with imiquimod 5% cream

2006; Wiley; Volume: 20; Issue: 7 Linguagem: Inglês

10.1111/j.1468-3083.2006.01552.x

1468-3083

JR Ferreres, Antonio Macaya, Anna Jucglá, Cristina Muniesa, Carlos Marrero Prats, Jordi Peyrı́,

Nonmelanoma Skin Cancer Studies

Journal of the European Academy of Dermatology and VenereologyVolume 20, Issue 7 p. 877-878 Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream JR Ferreres, Corresponding Author JR Ferreres * Corresponding author, tel. +0 34 93 260 79 32; fax +0 34 93 260 78 44; E-mail: [email protected]Search for more papers by this authorA Macaya, A Macaya Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorA Jucglà, A Jucglà Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorC Muniesa, C Muniesa Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorC Prats, C Prats Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorJ Peyrí, J Peyrí Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this author JR Ferreres, Corresponding Author JR Ferreres * Corresponding author, tel. +0 34 93 260 79 32; fax +0 34 93 260 78 44; E-mail: [email protected]Search for more papers by this authorA Macaya, A Macaya Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorA Jucglà, A Jucglà Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorC Muniesa, C Muniesa Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorC Prats, C Prats Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this authorJ Peyrí, J Peyrí Dermatology Service, Ciutat Sanitària i Universitària de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.Search for more papers by this author First published: 21 April 2006 https://doi.org/10.1111/j.1468-3083.2006.01552.xCitations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002–1007. 10.1016/S0190-9622(99)70261-6 CASPubMedWeb of Science®Google Scholar 2 Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577–579. 10.1046/j.1524-4725.2000.00003.x CASPubMedWeb of Science®Google Scholar 3 Marks R, Gebauer K, Schumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose–response trial. J Am Acad Dermatol 2001; 44: 807–813. 10.1067/mjd.2001.113689 CASPubMedWeb of Science®Google Scholar 4 Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722–733. 10.1016/j.jaad.2003.11.066 PubMedWeb of Science®Google Scholar 5 Marks R, Owens M, Walters SA. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Arch Dermatol 2004; 140: 1284–1285. 10.1001/archderm.140.10.1284-b PubMedWeb of Science®Google Scholar 6 Schumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol 2004; 140: 1286–1287. 10.1001/archderm.140.10.1286 PubMedWeb of Science®Google Scholar Citing Literature Volume20, Issue7August 2006Pages 877-878 ReferencesRelatedInformation